Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 32.09%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2025 (2026-03-31): 0.00%.
GROSS MARGIN
32.09%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 444 covered companies
CURRENT VS SECTOR MEDIAN
-25.22%
vs the sector median at left
Market Cap
$67.11M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$65.08M
Gross Margin
99.56%
TTM Avg
98.97%
3Y Avg
49.48%
5Y Avg
32.99%
Market Cap
$69.05M
Gross Margin
49.30%
TTM Avg
49.08%
3Y Avg
46.18%
5Y Avg
47.39%
Market Cap
$69.43M
Gross Margin
62.53%
TTM Avg
65.36%
3Y Avg
65.75%
5Y Avg
64.06%
Market Cap
$70.01M
Gross Margin
60.78%
TTM Avg
57.02%
3Y Avg
54.79%
5Y Avg
56.72%
Market Cap
$70.03M
Gross Margin
70.07%
TTM Avg
73.26%
3Y Avg
61.08%
5Y Avg
58.36%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $66.56M | 32.09% | 0.00% | 0.00% | N/A |
| PDS Biotechnology Corporation (PDSB)vs › | $67.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Gossamer Bio, Inc. (GOSS)vs › | $65.08M | 99.56% | 98.97% | 49.48% | 32.99% |
| InterCure Ltd. (INCR)vs › | $64.56M | 14.40% | 12.47% | 23.60% | 30.84% |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | 49.30% | 49.08% | 46.18% | 47.39% |
| Cingulate Inc. (CING)vs › | $63.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fortress Biotech, Inc. (FBIO)vs › | $69.43M | 62.53% | 65.36% | 65.75% | 64.06% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.01M | 60.78% | 57.02% | 54.79% | 56.72% |
| Heron Therapeutics, Inc. (HRTX)vs › | $70.03M | 70.07% | 73.26% | 61.08% | 58.36% |
| iBio, Inc. (IBIO)vs › | $72.02M | 100.00% | 100.00% | 75.00% | 39.52% |
Gross Margin
32.1%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 696.47% |
